Related Experiment Videos
Switching on-off Snail: LOXL2 versus GSK3beta
Héctor Peinado1, Francisco Portillo, Amparo Cano
1Departamento de Bioquímica, Universidad Autónoma de Madrid, Instituto de Investigaciones Biomódicas Alberto Sols, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid, Spain.
Cell Cycle (Georgetown, Tex.)
|November 19, 2005
Summary
Lysyl oxidase-like 2 (LOXL2) protein may regulate carcinoma progression by interacting with Snail, a key transcription factor. LOXL2 potentially stabilizes Snail by inhibiting its degradation, offering new insights into cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Epithelial-mesenchymal transition (EMT) is crucial for carcinoma progression.
- The transcription factor Snail regulates EMT by suppressing epithelial gene expression.
- Snail protein stability is controlled by GSK3beta-dependent phosphorylation and ubiquitination, leading to degradation.
Purpose of the Study:
- To investigate the interaction between Snail and LOXL2.
- To elucidate the role of LOXL2 in regulating Snail stability and degradation.
- To discuss the implications of this interaction in carcinoma progression.
Main Methods:
- The study discusses the known mechanisms of Snail regulation by GSK3beta.
- It highlights the recent finding of a physical and functional interaction between Snail and LOXL2.
- The text focuses on the potential impact of LOXL2 on Snail degradation.
Main Results:
- LOXL2 interacts with Snail.
- LOXL2 appears to attenuate the GSK3beta-dependent degradation of Snail.
- This interaction suggests a novel regulatory mechanism for Snail.
Conclusions:
- LOXL2 may play a significant role in carcinoma progression by modulating Snail stability.
- Understanding the LOXL2-Snail interaction provides new avenues for therapeutic strategies targeting cancer.
- Further research is warranted to fully explore this regulatory pathway.